M. Majidi

发表

GABAB receptor is a novel drug target for pancreatic cancer

H. Schuller, Hussein A. N. Al-Wadei, M. Majidi, 2008, Cancer.

Deletion of the COOH Terminus Converts the ST5 p70 Protein from an Inhibitor of RAS Signaling to an Activator with Transforming Activity in NIH-3T3 Cells*

J. Gutkind, M. Majidi, J. Lichy, 2000, The Journal of Biological Chemistry.

Activation of Extracellular Signal-regulated Kinase 2 by a Novel Abl-binding Protein, ST5*

M. Majidi, J. Lichy, A. Hubbs, 1998, The Journal of Biological Chemistry.

NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells.

T. Takahashi, H. Schuller, M. Majidi, 2006, International journal of cancer.

Nongenomic B Estrogen Receptors Enhance B 1 Adrenergic Signaling Induced by the Nicotine-Derived Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Human Small Airway Epithelial Cells

Takashi Takahashi, H. Schuller, Hussein A. N. Al-Wadei, 2007 .

Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas

P. Fedoročko, H. Plummer, H. Schuller, 2006, Anti-cancer drugs.

Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript.

J. Kopczyński, J. Lasota, M. Miettinen, 2002, The American journal of pathology.

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Jing Wang, J. Roth, V. Baladandayuthapani, 2016, Scientific Reports.

Expression of an isoform of the novel signal transduction protein ST5 is linked to cell morphology

M. Majidi, J. Lichy, A. Hubbs, 1999, Oncogene.

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

J. Minna, J. Roth, S. Swisher, 2015, Oncotarget.

Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma

H. Schuller, Hussein A. N. Al-Wadei, M. Majidi, 2008, Carcinogenesis.

A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer

Sourav Bandyopadhyay, J. Roth, J. Riess, 2021, bioRxiv.

Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Markku Miettinen, J. Lasota, M. Miettinen, 2002, European journal of cancer.

TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models

Jing Wang, J. Roth, V. Baladandayuthapani, 2018, Cancer Immunology Research.

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Yvonne A. Evrard, Michael W. Lloyd, Jeffrey H. Chuang, 2021, Nature Genetics.

Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas

M. Miettinen, M. Majidi, J. Fanburg-Smith, 2006, Modern Pathology.

Nongenomic β Estrogen Receptors Enhance β1 Adrenergic Signaling Induced by the Nicotine-Derived Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Human Small Airway Epithelial Cells

Takashi Takahashi, H. Schuller, Hussein A. N. Al-Wadei, 2007 .

An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses

Jeffrey S. Morris, J. Roth, Steven H. Lin, 2019, Cancer Immunology Research.

Low concentrations of beta-carotene stimulate the proliferation of human pancreatic duct epithelial cells in a PKA-dependent manner.

M. Tsao, H. Schuller, M. Majidi, 2007, Cancer genomics & proteomics.

Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2‐adrenergic receptor single‐nucleotide polymorphisms

J. Becker, M. Majidi, T. Masi, 2005, Genes, chromosomes & cancer.

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

Jing Wang, J. Roth, J. Riess, 2021, bioRxiv.

KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.

K. Coombes, J. Minna, J. Roth, 2013, Cancer research.

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model

J. Roth, E. Shpall, R. Shao, 2022, Communications biology.

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy

Jing Wang, J. Roth, V. Baladandayuthapani, 2015, PloS one.

Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells

Jing Wang, J. Roth, I. Wistuba, 2019, Oncogene.

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

Jing Wang, J. Roth, B. Dai, 2017, Oncotarget.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

S. Hanash, J. Roth, S. Swisher, 2017, Cancer immunology research.

Differential expression of the human ST5 gene in HeLa-fibroblast hybrid cell lines mediated by YY1: evidence that YY1 plays a part in tumor suppression.

M. Majidi, J. Lichy, M. Tsai, 1996, Nucleic acids research.

The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner

J. Minna, J. Roth, J. Meng, 2013, PloS one.

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts

Steven B. Neuhauser, Yvonne A. Evrard, Michael W. Lloyd, 2019, Nature Genetics.

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

Yvonne A. Evrard, David M. Rocke, Jessica J. Andrews, 2022, NAR cancer.

Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells.

Takashi Takahashi, H. Schuller, Hussein A. N. Al-Wadei, 2007, Cancer Research.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

S. Hanash, J. Roth, S. Swisher, 2017, Cancer Immunology Research.